Regulatory Update: RFK Jr. announced Feb 2026 — 14 peptides expected to return to legal compounding status. Reclassification pending. Learn more

← Back to Peptide Guides
Peptide Profiles: What Buyers Need To Know7 min read

CJC-1295 (Growth Hormone-Releasing Hormone)

CJC-1295 is one of the most widely used growth hormone releasing peptides. Here's your complete guide to sourcing it safely.

What Is CJC-1295?

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) — a 30-amino-acid peptide that stimulates the pituitary gland to produce and release growth hormone naturally. It exists in two distinct forms with very different profiles.

The CJC-1295 + Ipamorelin combination is the most widely prescribed peptide stack in clinical practice. Understanding which version of CJC-1295 you're buying is the single most important thing to get right.


The Two Versions: DAC vs. No DAC

This is the most critical distinction when buying CJC-1295. These are not interchangeable.

PropertyCJC-1295 with DACCJC-1295 without DAC (Mod GRF 1-29)
Molecular Weight~3,647 Da~3,367 Da
Half-Life6-8 days~30 minutes
GH Release PatternSustained, elevatedPulsatile, natural
Dosing FrequencyLess frequentMore frequent
Albumin BindingYes (lysine linker)No
Clinical PreferenceLess commonMore common (paired with Ipamorelin)

Quick Facts

PropertyDetail
TypeGHRH analog
Amino Acids30
MechanismStimulates natural GH production (not replacement)
Regulatory StatusExpected Category 1 reclassification
Most Common PairingIpamorelin (growth hormone secretagogue)

Research Areas of Interest

  • Growth hormone optimization — stimulates natural GH production rather than replacing it
  • Body composition — studied for effects on lean mass and fat metabolism
  • Recovery and repair — research interest in tissue healing and sleep quality
  • Synergy with GHSs — amplified effects when paired with secretagogues like Ipamorelin

How It's Sold

SourceFormPrescription?Typical Cost
Research VendorsLyophilized powder, 2mg (no DAC)No$25-55/vial
Research VendorsLyophilized powder, 2mg (with DAC)No$35-70/vial
Compounding PharmacyInjectable (subcutaneous)Yes$150-350+/month
Compounding PharmacyCJC-1295/Ipamorelin combo vialYes$200-450+/month

What to Look For on the COA

  • HPLC purity — minimum 95%, preferably 98-99%+
  • Mass spectrometry — this is how you verify which version you have:

- No DAC: ~3,367 Da

- With DAC: ~3,647 Da

  • Variant identification — the COA must clearly state which version was tested
  • Endotoxin testing — required for injectable forms
  • Amino acid analysis — confirms correct sequence

If a vendor's COA shows a molecular weight that doesn't match either variant (~3,367 or ~3,647 Da), do not purchase. Ambiguous labeling that doesn't specify DAC vs. no DAC is also a red flag.


Storage Guide

FormTemperatureShelf Life
Lyophilized (powder)2-8°CMonths (stable)
Reconstituted2-8°C21-28 days
  • Protect from light at all times
  • Do not freeze reconstituted solutions

Key Sourcing Tips

  1. Always verify DAC vs. no DAC — this is the most common source of confusion and the most important thing to check
  2. For research: compare COAs across vendors and verify molecular weight matches the correct variant
  3. For clinical use: CJC-1295 (no DAC) + Ipamorelin from a compounding pharmacy is the standard protocol
  4. Be wary of extremely cheap CJC-1295 — the with-DAC version requires more complex synthesis
  5. If mass spec data on the COA doesn't match either variant's expected weight, avoid that source entirely